{"id":"NCT02149108","sponsor":"Boehringer Ingelheim","briefTitle":"Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)","officialTitle":"A Double-blind, Randomised, Placebo Controlled Phase III Study of Nintedanib Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Patients With Metastatic Colorectal Cancer Refractory to Standard Therapies.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-09-25","primaryCompletion":"2016-05-13","completion":"2016-08-25","firstPosted":"2014-05-29","resultsPosted":"2017-07-21","lastUpdate":"2017-07-21"},"enrollment":768,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Colorectal Neoplasms"],"interventions":[{"type":"DRUG","name":"Nintedanib (BIBF 1120)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"BSC","otherNames":[]},{"type":"DRUG","name":"BSC","otherNames":[]}],"arms":[{"label":"Nintedanib (BIBF 1120) + BSC","type":"EXPERIMENTAL"},{"label":"Placebo + BSC","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this Phase III study is to evaluate the efficacy of nintedanib in patients with metastatic colorectal cancer (mCRC) after failure of previous treatment with standard chemotherapy and biological agents.","primaryOutcome":{"measure":"Progression-Free Survival (PFS) by Central Review Assessment","timeFrame":"From randomisation until cut-off date 14JUN2016.","effectByArm":[{"arm":"Placebo","deltaMin":1.38,"sd":null},{"arm":"Nintedanib","deltaMin":1.51,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":16,"exclusionCount":11},"locations":{"siteCount":129,"countries":["United States","Argentina","Australia","Austria","Belgium","Canada","Czechia","Denmark","France","Germany","Hong Kong","Israel","Italy","Japan","Mexico","Netherlands","Poland","Portugal","Russia","South Korea","Spain","Sweden","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["30010751","26603056"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":133,"n":381},"commonTop":["Nausea","Diarrhoea","Decreased appetite","Vomiting","Fatigue"]}}